Trial intelligence / Profile preview

Acupuncture in Acute Idiopathic Hearing Loss With Tinnitus

DRKS00012664Phase 4Recruiting

Sponsor
Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie
Start
Jun 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of prednisolone in tinnitus and idiopathic sudden sensorineural hearing loss (ISSNHL) (3 arms), sponsored by Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie. Started Jun 2017; status: recruiting.

02

Drugs

prednisolone
03

Conditions

tinnitusidiopathic sudden sensorineural hearing loss (ISSNHL)

Beyond the preview

Go deeper on DRKS00012664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00012664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call